Cargando…

Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency

Mutations resulting in haploinsufficiency of progranulin (PGRN) cause frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP), a devastating neurodegenerative disease. Accumulating evidence suggest a crucial role of progranulin in maintaining proper lysosomal function during agi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaolai, Sun, Lirong, Brady, Owen Adam, Murphy, Kira A., Hu, Fenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270347/
https://www.ncbi.nlm.nih.gov/pubmed/28126008
http://dx.doi.org/10.1186/s40478-017-0412-1
_version_ 1782501173277753344
author Zhou, Xiaolai
Sun, Lirong
Brady, Owen Adam
Murphy, Kira A.
Hu, Fenghua
author_facet Zhou, Xiaolai
Sun, Lirong
Brady, Owen Adam
Murphy, Kira A.
Hu, Fenghua
author_sort Zhou, Xiaolai
collection PubMed
description Mutations resulting in haploinsufficiency of progranulin (PGRN) cause frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP), a devastating neurodegenerative disease. Accumulating evidence suggest a crucial role of progranulin in maintaining proper lysosomal function during aging. TMEM106B has been identified as a risk factor for frontotemporal lobar degeneration with progranulin mutations and elevated mRNA and protein levels of TMEM106B are associated with increased risk for frontotemporal lobar degeneration. Increased levels of TMEM106B alter lysosomal morphology and interfere with lysosomal degradation. However, how progranulin and TMEM106B interact to regulate lysosomal function and frontotemporal lobar degeneration (FTLD) disease progression is still unclear. Here we report that progranulin deficiency leads to increased TMEM106B protein levels in the mouse cortex with aging. To mimic elevated levels of TMEM106B in frontotemporal lobar degeneration (FTLD) cases, we generated transgenic mice expressing TMEM106B under the neuronal specific promoter, CamKII. Surprisingly, we found that the total protein levels of TMEM106B are not altered despite the expression of the TMEM106B transgene at mRNA and protein levels, suggesting a tight regulation of TMEM106B protein levels in the mouse brain. However, progranulin deficiency results in accumulation of TMEM106B protein from the transgene expression during aging, which is accompanied by exaggerated lysosomal abnormalities and increased lipofuscin accumulation. In summary, our mouse model nicely recapitulates the interaction between progranulin and TMEM106B in human patients and supports a critical role of lysosomal dysfunction in the frontotemporal lobar degeneration (FTLD) disease progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0412-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5270347
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52703472017-02-01 Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency Zhou, Xiaolai Sun, Lirong Brady, Owen Adam Murphy, Kira A. Hu, Fenghua Acta Neuropathol Commun Research Mutations resulting in haploinsufficiency of progranulin (PGRN) cause frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP), a devastating neurodegenerative disease. Accumulating evidence suggest a crucial role of progranulin in maintaining proper lysosomal function during aging. TMEM106B has been identified as a risk factor for frontotemporal lobar degeneration with progranulin mutations and elevated mRNA and protein levels of TMEM106B are associated with increased risk for frontotemporal lobar degeneration. Increased levels of TMEM106B alter lysosomal morphology and interfere with lysosomal degradation. However, how progranulin and TMEM106B interact to regulate lysosomal function and frontotemporal lobar degeneration (FTLD) disease progression is still unclear. Here we report that progranulin deficiency leads to increased TMEM106B protein levels in the mouse cortex with aging. To mimic elevated levels of TMEM106B in frontotemporal lobar degeneration (FTLD) cases, we generated transgenic mice expressing TMEM106B under the neuronal specific promoter, CamKII. Surprisingly, we found that the total protein levels of TMEM106B are not altered despite the expression of the TMEM106B transgene at mRNA and protein levels, suggesting a tight regulation of TMEM106B protein levels in the mouse brain. However, progranulin deficiency results in accumulation of TMEM106B protein from the transgene expression during aging, which is accompanied by exaggerated lysosomal abnormalities and increased lipofuscin accumulation. In summary, our mouse model nicely recapitulates the interaction between progranulin and TMEM106B in human patients and supports a critical role of lysosomal dysfunction in the frontotemporal lobar degeneration (FTLD) disease progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0412-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-26 /pmc/articles/PMC5270347/ /pubmed/28126008 http://dx.doi.org/10.1186/s40478-017-0412-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhou, Xiaolai
Sun, Lirong
Brady, Owen Adam
Murphy, Kira A.
Hu, Fenghua
Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
title Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
title_full Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
title_fullStr Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
title_full_unstemmed Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
title_short Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
title_sort elevated tmem106b levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270347/
https://www.ncbi.nlm.nih.gov/pubmed/28126008
http://dx.doi.org/10.1186/s40478-017-0412-1
work_keys_str_mv AT zhouxiaolai elevatedtmem106blevelsexaggeratelipofuscinaccumulationandlysosomaldysfunctioninagedmicewithprogranulindeficiency
AT sunlirong elevatedtmem106blevelsexaggeratelipofuscinaccumulationandlysosomaldysfunctioninagedmicewithprogranulindeficiency
AT bradyowenadam elevatedtmem106blevelsexaggeratelipofuscinaccumulationandlysosomaldysfunctioninagedmicewithprogranulindeficiency
AT murphykiraa elevatedtmem106blevelsexaggeratelipofuscinaccumulationandlysosomaldysfunctioninagedmicewithprogranulindeficiency
AT hufenghua elevatedtmem106blevelsexaggeratelipofuscinaccumulationandlysosomaldysfunctioninagedmicewithprogranulindeficiency